Sex Steroid Hormone and Ophthalmic Disease

성호르몬과 안질환

  • Kim, Jin-Ju (Department of Obstetrics and Gynecology, Seoul National University College of Medicine) ;
  • Yu, Hyeong-Gon (Department of Ophthalmology, Seoul National University College of Medicine) ;
  • Ku, Seung-Yup (Department of Obstetrics and Gynecology, Seoul National University College of Medicine)
  • 김진주 (서울대학교 의과대학 산부인과학교실) ;
  • 유형곤 (서울대학교 의과대학 안과학교실) ;
  • 구승엽 (서울대학교 의과대학 산부인과학교실)
  • Received : 2010.02.20
  • Accepted : 2010.04.14
  • Published : 2010.06.30

Abstract

Sex and its tropic hormones influence the lacrimal system, corneal anatomy and disease, aqueous humor dynamics and glaucoma, crystalline lens and cataract, and retinal disease. Dry eye occurs especially frequently during pregnancy, oral contraceptive use, and after menopause, during which androgen levels decrease. Androgen control development, differentiation, and lipid production of sebaceous glands throughout the body, and androgen deficiency also leads to meibomian gland dysfunction and evaporative dry eye. On the other hand, estrogen causes a reduction in size, activity, and lipid production of sebaceous glands. Sex and its tropic hormones also influence the corneal anatomy and disease, and corneal thickening occurred on the second day of the menstrual cycle and around the time of ovulation and appeared to be related to estrogen levels. Fuchs' dystrophy is more commonly seen in postmenopausal women than men and may be linked to hormonal changes that occur with aging. In addition, overexpression of estrogen and progesterone receptors in the conjunctiva of vernal keratoconjunctivitis patients. Serum progesterone levels also may be associated with intraocular pressure especially in pregnant women, and for the women. For women with cataracts, hormone levels were typical of menopause, and there was a significant negative correlation between estradiol and follicular stimulating hormone levels. In addition, serum testosterone levels are associated with the development of diabetic retinopathy. Although the role of sex hormones on the eye is largely unknown, and the results should be interpreted with caution until replicated, the functions of sex hormones in ocular disease remains to be investigated, because they may be involved in structure and function of the ocular components, which are important in the pathogenesis of ocular disease.

성호르몬은 lacrimal system, corneal anatomy and disease, aqueous humor dynamics and glaucoma, crystalline lens and cataract, retinal disease를 포함한 안과영역의 다양한 부위에 영향을 끼칠 수 있다. Androgen은 전신에 걸친 sebaceous glands의 발달, 분화, 지질생성 등에 관여하므로 androgen deficiency는 meibomian gland의 기능장애와 건성안에서 증발을 더욱더 심화시킬 수 있는 것으로 알려져 있다. 반면에 estrogens은 sebaceous glands의 크기, activity, 지질생성을 감소시켜 meibomian gland에서는 androgen과 반대되는 작용을 할 가능성이 있다. 성호르몬은 또한 각막의 구조와 질병경과에도 영향을 줄 수 있는데, 각막이 월경주기 제2일째 및 배란주위기에 두꺼워지며, 폐경 여성에서 여성호르몬 치료 시 각막두께가 증가한다는 사실은 estrogen levels과 각막 두께와의 연관을 시사하는 소견이라고 하겠다. Fuch's dystrophy 역시 폐경 후 여성에서 더 흔히 관찰되어, 나이에 따른 호르몬 변화가 그 원인 중 하나로 지목되고 있으며, vernal keratoconjunctivitis 환자의 각막조직에서는 estrogen과 progesterone 수용체의 overexpresson이 발견되어 역시 이들 질환에서의 성호르몬의 역할을 시사한다고 할 수 있겠다. 성호르몬은 안압에도 영향을 미칠 수 있는데, intraocular pressure와 혈중 luteinizing hormone, follicular stimulating hormone (FSH), estrone, estradiol, progesterone, testosterone과는 연관이 없는 것으로 보고한 결과도 있으나, 혈중 progesterone의 경우 특히 임신중인 여성에서 안압과의 연관관계가 보고되었으며, 또한 폐경 여성에서 혈중 남성호르몬 농도가 높을수록 안압이 상승하는 경향이 있음이 보고되었다. 한편 'Female sex'는 모든 종류의 백내장의 위험요소인 것으로 알려져 있다. 백내장으로 진단받은 여성의 경우 호르몬 측정 시 연령등을 보정하고도 폐경기에 가까운 호르몬 수치를 보였으며, 이들 백내장 환자군내에서는 estradiol과 FSH 농도 사이에 유의한 음의 상관관계가 보고되었다. 또한 DHEAS의 경우 백내장 위험도를 감소시키는 것으로 보고되었고, 그 기전으로 전구호르몬인 DHEA의 역할을 제시되고 있는데. 즉 백내장의 주요 기전 중 하나인 oxidative stress를 감소시키는 antioxidant activity를 DHEA가 보이기 때문일 것으로 추정되고 있다. 성호르몬은 망막 내 혈관의 흐름에도 영향을 줄 수 있는 것으로 알려져 있는데, 안구 내 혈류에서 여성호르몬의 긍정적인 효과와 남성호르몬의 부정적인 효과가 보고되었고, age-related macular degeneration (AMD)의 경우, estradiol이 ER-$\beta$ 수용체를 통해 보호효과가 있음이 보고되어, ER-$\beta$ 수용체가 향후 AMD 치료에서 치료적 target이 될 수도 있을 것으로 알려지고 있다. 또한 DHEAS의 경우 AMD 위험도를 증가시킬 가능성이 있으며, 당뇨로 진단받은 환자에서는 혈중 testosterone 농도는 당뇨병성 망막병증의 진행과 연관이 있는 것으로 보고되었다. 성호르몬은 안과영역의 다양한 질환과의 연관관계는 아직 추가연구가 필요한 실정이나 다양한 성호르몬이 안질환의 발생 및 경과에 영향을 줄 가능성이 있으며, 이와 같은 연관관계가 규명된다면 추후 호르몬을 통해 질환의 경과 및 예방의 가능성이 제시될 수도 있을 것으로 사료된다. 특히 폐경이후 다양한 안질환이 증가한다는 기존의 연구결과들을 고려 시, 안과영역에 있어 폐경기 여성호르몬 치료의 긍정적인 역할에 관해서는 지속적인 관심이 요구된다고 하겠다.

Keywords

References

  1. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000; 78: 146-53. https://doi.org/10.1034/j.1600-0420.2000.078002146.x
  2. Gupta PD, Johar K Sr, Nagpal K, Vasavada AR. Sex hormone receptors in the human eye. Surv Ophthalmol 2005; 50: 274-84. https://doi.org/10.1016/j.survophthal.2005.02.005
  3. Coca-Prados M, Ghosh S, Wang Y, Escribano J, Herrala A, Vihko P. Sex steroid hormone metabolism takes place in human ocular cells. J Steroid Biochem Mol Biol 2003; 86: 207-16. https://doi.org/10.1016/j.jsbmb.2003.08.001
  4. Schirra F, Suzuki T, Dickinson DP, Townsend DJ, Gipson IK, Sullivan DA. Identification of steroidogenic enzyme mRNAs in the human lacrimal gland, meibomian gland, cornea, and conjunctiva. Cornea 2006; 25: 438-42. https://doi.org/10.1097/01.ico.0000183664.80004.44
  5. Yu HG, Ku SY, Choi J, Kim H, Suh CS, Kim SH, et al. Sex steroid and tropic hormone levels may be associated with postoperative prognosis of vitrectomy in Korean postmenopausal women: a pilot study. Menopause 2010; 17: 161-5. https://doi.org/10.1097/gme.0b013e3181aa2734
  6. Bandeen-Roche K, Munoz B, Tielsch JM, West SK, Schein OD. Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci 1997; 38: 2469-75.
  7. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998; 105: 1114-9. https://doi.org/10.1016/S0161-6420(98)96016-X
  8. Sullivan DA. Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye. Ocul Surf 2004; 2: 92-123. https://doi.org/10.1016/S1542-0124(12)70147-7
  9. Mathers WD, Stovall D, Lane JA, Zimmerman MB, Johnson S. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 1998; 17: 353-8. https://doi.org/10.1097/00003226-199807000-00002
  10. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000; 118: 1264-8. https://doi.org/10.1001/archopht.118.9.1264
  11. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA 2001; 286: 2114-9. https://doi.org/10.1001/jama.286.17.2114
  12. Barney NP. Can hormone replacement therapy cause dry eye? Arch Ophthalmol 2002; 120: 641-2. https://doi.org/10.1001/archopht.120.5.641
  13. Wenderlein M, Mattes S. The "dry eye" phenomenon and ovarian function. Study of 700 women pre- and postmenopausal. Zentralbl Gynakol 1996; 118: 643-9.
  14. Nichols KK, Jones LA, Jackson RD, Zadnik K. Dry eye in postmenopausal women enrolled in the observational study cohort of the Women's Health Initiative [ARVO Abstract]. Invest Ophthalmol Vis Sci 2003; 44: 2462.
  15. Warren DW, Azzarolo AM, Becker L, Bjerrum K, Kaswan RL, Mircheff AK. Effects of dihydrotestosterone and prolactin on lacrimal gland function. Adv Exp Med Biol 1994; 350: 99-104. https://doi.org/10.1007/978-1-4615-2417-5_17
  16. Park SB, Lindahl KJ, Temnycky GO, Aquavella JV. The effect of pregnancy on corneal curvature. CLAO J 1992; 18: 256-9.
  17. Serrander AM, Peek KE. Changes in contact lens comfort related to the menstrual cycle and menopause. A review of articles. J Am Optom Assoc 1993; 64: 162-6.
  18. Wagner H, Fink BA, Zadnik K. Sex- and gender-based differences in healthy and diseased eyes. Optometry 2008; 79: 636-52. https://doi.org/10.1016/j.optm.2008.01.024
  19. Tamer C, Oksuz H, Sogut S. Androgen status of the nonautoimmune dry eye subtypes. Ophthalmic Res 2006; 38: 280-6. https://doi.org/10.1159/000095771
  20. Sullivan DA, Schaumberg DA, Suzuki T, Schirra F, Liu M, Richards S, et al. Sex steroids, meibomian gland dysfunction and evaporative dry eye in Sjogren's syndrome. Lupus 2002; 11: 667. https://doi.org/10.1191/0961203302lu275oa
  21. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol 2002; 506: 449-58.
  22. Yamagami H, Richards SM, Sullivan BD, Liu M, Steagall RJ, Sullivan DA. Gender-associated differences in gene expression of the meibomian gland. Adv Exp Med Biol 2002; 506: 459- 63.
  23. Kiely PM, Carney LG, Smith G. Menstrual cycle variations of corneal topography and thickness. Am J Optom Physiol Opt 1983; 60: 822-9. https://doi.org/10.1097/00006324-198310000-00003
  24. Manchester PT Jr. Hydration of the cornea. Trans Am Ophthalmol Soc 1970; 68: 425-61.
  25. Feldman F, Bain J, Matuk AR. Daily assessment of ocular and hormonal variables throughout the menstrual cycle. Arch Ophthalmol 1978; 96: 1835-8. https://doi.org/10.1001/archopht.1978.03910060347010
  26. Hirji NK, Larke JR. Thickness of human cornea measured by topographic pachometry. Am J Optom Physiol Opt 1978; 55: 97-100. https://doi.org/10.1097/00006324-197802000-00006
  27. el-Hage SG, Beaulne C. Changes in central and peripheral corneal thickness with menstrual cycle. Am J Optom Arch Am Acad Optom 1973; 50: 863-71. https://doi.org/10.1097/00006324-197311000-00004
  28. Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol 1988; 105: 258-60. https://doi.org/10.1016/0002-9394(88)90006-2
  29. Ziai N, Ory SJ, Khan AR, Brubaker RF. Beta-human chorionic gonadotropin, progesterone, and aqueous dynamics during pregnancy. Arch Ophthalmol 1994; 112: 801-6. https://doi.org/10.1001/archopht.1994.01090180099043
  30. Sanchis-Gimeno JA, Lleo-Perez A, Alonso L, Rahhal MS, Martinez-Soriano F. Reduced corneal thickness values in postmenopausal women with dry eye. Cornea 2005; 24: 39-44. https://doi.org/10.1097/01.ico.0000138836.45070.0f
  31. Sorrentino C, Affinito P, Mattace Raso F, Loffredo M, Merlino P, Loffredo A, et al. Effect of hormone replacement therapy on postmenopausal ocular function. Minerva Ginecol 1998; 50: 19-24.
  32. Affinito P, Di Spiezio Sardo A, Di Carlo C, Sammartino A, Tommaselli GA, Bifulco G, et al. Effects of hormone replacement therapy on ocular function in postmenopause. Menopause 2003; 10: 482-7. https://doi.org/10.1097/01.GME.0000063568.84134.35
  33. van Bijsterveld OP, Mansour KH, Dubois FJ. Thygeson's superficial punctate keratitis. Ann Ophthalmol 1985; 17: 150-3.
  34. Nagra PK, Rapuano CJ, Cohen EJ, Laibson PR. Thygeson's superficial punctate keratitis: ten years' experience. Ophthalmology 2004; 111: 34-7. https://doi.org/10.1016/j.ophtha.2003.05.002
  35. Johnson DH, Bourne WM, Campbell RJ. The ultrastructure of Descemet's membrane. I. Changes with age in normal corneas. Arch Ophthalmol 1982; 100: 1942-7. https://doi.org/10.1001/archopht.1982.01030040922011
  36. Bonini S, Lambiase A, Schiavone M, Centofanti M, Palma LA. Estrogen and progesterone receptors in vernal keratoconjunctivitis. Ophthalmology 1995; 102: 1374-9. https://doi.org/10.1016/S0161-6420(95)30861-5
  37. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye (Lond) 2004; 18: 345-51. https://doi.org/10.1038/sj.eye.6700675
  38. Zhang XH, Sun HM, Ji J, Zhang H, Ma WJ, Jin Z, et al. Sex hormones and their receptors in patients with age-related cataract. J Cataract Refract Surg 2003; 29: 71-7. https://doi.org/10.1016/S0886-3350(02)01436-0
  39. Lim KJ, Hyung SM, Youn DH. Ocular dimensions with aging in normal eyes. Korean J Ophthalmol 1992; 6: 19-31. https://doi.org/10.3341/kjo.1992.6.1.19
  40. Razeghinejad MR, Amini H, Esfandiari H. Lesser anterior chamber dimensions in women may be a predisposing factor for malignant glaucoma. Med Hypotheses 2005; 64: 572-4. https://doi.org/10.1016/j.mehy.2004.07.035
  41. Qureshi IA. Intraocular pressure: association with menstrual cycle, pregnancy and menopause in apparently healthy women. Chin J Physiol 1995; 38: 229-34.
  42. Qureshi IA, Huang YB, Xi XR, Wu XD. Hormonal changes associated with menstrual cycle have no definite influence on ocular pressure. Proc Natl Sci Counc Repub China B 1997; 21: 49-53.
  43. Qureshi IA, Xi XR, Wu XD, Pasha N, Huang YB. Variations in ocular pressure during menstrual cycle. J Pak Med Assoc 1998; 48: 37-40.
  44. Toker E, Yenice O, Temel A. Influence of serum levels of sex hormones on intraocular pressure in menopausal women. J Glaucoma 2003; 12: 436-40. https://doi.org/10.1097/00061198-200310000-00007
  45. Brubaker RF. Flow of aqueous humor in humans [The Friedenwald Lecture]. Invest Ophthalmol Vis Sci 1991; 32: 3145-66.
  46. Gharagozloo NZ, Brubaker RF. The correlation between serum progesterone and aqueous dynamics during the menstrual cycle. Acta Ophthalmol (Copenh) 1991; 69: 791-5.
  47. Abramov Y, Borik S, Yahalom C, Fatum M, Avgil G, Brzezinski A, et al. Does postmenopausal hormone replacement therapy affect intraocular pressure? J Glaucoma 2005; 14: 271-5. https://doi.org/10.1097/01.ijg.0000169390.17427.b7
  48. Huber JC, Schneeberger C, Tempfer CB. Genetic modelling of the estrogen metabolism as a risk factor of hormonedependent disorders. Maturitas 2002; 42: 1-12. https://doi.org/10.1016/S0378-5122(02)00021-X
  49. Qureshi IA. Ocular hypertensive effect of menopause with and without systemic hypertension. Acta Obstet Gynecol Scand 1996; 75: 266-9. https://doi.org/10.3109/00016349609047099
  50. Hulsman CA, Westendorp IC, Ramrattan RS, Wolfs RC, Witteman JC, Vingerling JR, et al. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 2001; 154: 138-44. https://doi.org/10.1093/aje/154.2.138
  51. Pasquale LR, Kang J, Rosner B, Willett W, Hankinson S. Age at menopause and primary open-angle glaucoma: a prospective study [ARVO Abstract]. Invest Ophthalmol Vis Sci 2003; 44: 795.
  52. Dolatowska E. The evaluation of estradiol and FSH serum levels in menopausal women with primary cataract. Klin Oczna 2002; 104: 357-61.
  53. Defay R, Pinchinat S, Lumbroso S, Sultan C, Papoz L, Delcourt C. Relationships between hormonal status and cataract in french postmenopausal women: the POLA study. Ann Epidemiol 2003; 13: 638-44. https://doi.org/10.1016/S1047-2797(03)00058-9
  54. Toker E, Yenice O, Akpinar I, Aribal E, Kazokoglu H. The influence of sex hormones on ocular blood flow in women. Acta Ophthalmol Scand 2003; 81: 617-24. https://doi.org/10.1111/j.1395-3907.2003.00160.x
  55. Evans JR, Schwartz SD, McHugh JD, Thamby-Rajah Y, Hodgson SA, Wormald RP, et al. Systemic risk factors for idiopathic macular holes: a case-control study. Eye (Lond) 1998; 12(Pt 2): 256-9. https://doi.org/10.1038/eye.1998.60
  56. Kumagai K, Ogino N, Demizu S, Atsumi K, Kurihara H, Iwaki M, et al. Clinical features of idiopathic macular holes. Nippon Ganka Gakkai Zasshi 2000; 104: 819-2557.
  57. Risk factors for idiopathic macular holes. The Eye Disease Case-Control Study Group. Am J Ophthalmol 1994; 118: 754-61. https://doi.org/10.1016/S0002-9394(14)72555-3
  58. Lei J, Silbiger S, Ziyadeh FN, Neugarten J. Serum-stimulated alpha 1 type IV collagen gene transcription is mediated by TGF-beta and inhibited by estradiol. Am J Physiol 1998; 274: F252-8.
  59. Potier M, Elliot SJ, Tack I, Lenz O, Striker GE, Striker LJ, et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol 2001; 12: 241-51.
  60. Elliot S, Catanuto P, Fernandez P, Espinosa-Heidmann D, Karl M, Korach K, et al. Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells. Exp Eye Res 2008; 86: 653-60. https://doi.org/10.1016/j.exer.2008.01.010
  61. Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C. Sex steroids and age-related macular degeneration in older French women: the POLA study. Ann Epidemiol 2004; 14: 202-8. https://doi.org/10.1016/S1047-2797(03)00130-3
  62. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 1998; 39: 233-52.
  63. Hill DJ, Flyvbjerg A, Arany E, Lauszus FF, Klebe JG. Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women with retinopathy. J Clin Endocrinol Metab 1997; 82: 1452-7. https://doi.org/10.1210/jc.82.5.1452
  64. Loukovaara S, Immonen IJ, Yandle TG, Nicholls G, Hiilesmaa VK, Kaaja RJ. Vasoactive mediators and retinopathy during type 1 diabetic pregnancy. Acta Ophthalmol Scand 2005; 83: 57-62. https://doi.org/10.1111/j.1600-0420.2005.00384.x
  65. Loukovaara S, Immonen I, Koistinen R, Hiilesmaa V, Kaaja R. Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes. Eye (Lond) 2005; 19: 422-30. https://doi.org/10.1038/sj.eye.6701499
  66. Haffner SM, Klein R, Dunn JF, Moss SE, Klein BE. Increased testosterone in type I diabetic subjects with severe retinopathy. Ophthalmology 1990; 97: 1270-4. https://doi.org/10.1016/S0161-6420(90)32428-4